U.S. Markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.48+0.05 (+1.46%)
At close: 4:00PM EDT

3.33 -0.15 (-4.45%)
After hours: 4:18PM EDT

People also watch

Agile Therapeutics, Inc.

101 Poor Farm Road
Princeton, NJ 08540
United States

IndustryDrugs - Generic
Full Time Employees17

Key Executives

Mr. Alfred F. AltomariChairman, Chief Exec. Officer and Pres733.14kN/A58
Mr. Scott M. CoianteCFO & Sr. VP434.52kN/A50
Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.Chief Medical Officer and Sr. VP532.43kN/A49
Mr. Geoffrey P. GilmoreGen. CounselN/AN/A51
Ms. Renee E. SelmanChief Commercial OfficerN/AN/A55
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Agile Therapeutics, Inc., a forward-thinking women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, also known as AG200-15, a once-weekly contraceptive patch, which completed Phase III clinical trials. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of August 1, 2017 is 9. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.